Medication Management and Diversion Control

Size: px
Start display at page:

Download "Medication Management and Diversion Control"

Transcription

1 Medication Management and Diversion Control Karla M Miller, Pharm D July 2017 January 18, 2017 NEWS Surgery Center Director Removed from Position after Alleged Drug Theft Director of the surgery center on the Luther campus on the Mayo Clinic Health System charged with 3 felonies and 3 misdemeanors for allegedly stealing drugs from the surgery center. The former Director admitted to taking and using narcotics one month before being caught and also confessed to stealing several hundred vials of Benadryl. The system believes that no patients were harmed during this process. 1

2 Scope of the Opioid Epidemic 13 of the highest prescribing states for painkillers have HCA facilities 249 million Rx In 2015 there were over 22,000 deaths involving prescription opioids, equivalent to about 62 deaths per day. Centers for Disease Control and Prevention (CDC). Injury prevention and control: Opioid overdose

3 Substance Abuse: Healthcare Professionals It is estimated that 10% of healthcare workers are dependent on some type of drug. Healthcare Professionals versus General Population: o Unique patterns o Disproportionate misuse of prescription drugs by healthcare workers compared to street drugs o Tendencies occur based on the medications readily available Drug diversion in the healthcare setting is difficult to measure Substance Use Disorder: Anesthesiologist Anesthesiologists make up <4% of physicians, but make up 13% of physicians treated for chemical dependency 3x higher than other medical fields Inhalational anesthetics make up only 2% of substances abused by anesthesiologists Sevoflurane has been reported as the drug of choice among the inhalational agents Despite preventative actions, incidence is not decreasing Risk Factors Individual susceptibility Long monotonous working hours Fatigable work shifts Personal problems Easy accessibility to drugs Bajwa SJS. Kaur J. Risk and safety concerns in anesthesiology practice: The present perspective. Anesth Essays Res. 2012;6(1): Warner DO, Berge K, Sun H, Harman A, Hanson A, Schroeder DR. Substance Use Disorder Among Anesthesiology Residents, JAMA. 2013;310(21): doi: /jama Hines R. Substance abuse in anesthesia providers: An update. Accessed February 22,

4 A Patient and Employee Safety Threat Patient Safety Diversion and opioid tampering has emerged as the leading cause of provider to patient HCV transmission Patients not receiving adequate pain control Patients receiving care from an impaired practitioner Patients not receiving appropriate level of service Employee Safety Harm to another employee Harm to self Suicide Compromised Patient Safety Due to Diversion Six recent examples of Hepatitis C Virus (HCV) transmission associated with injectable opiates 2004 TX Hospital Nurse Anesthetist 16 surgery patients infected 2009 >8,000 Patients Notified, CO Hospital Surgical Technician 26 surgery patients infected 2010 >3,900 Patients Notified, FL Hospital Radiology Technician 5 surgery patients infected 2012 >11,000 Patients Notified (16 facilities, 8 states) Radiology Technician 45 hospital patients infected 2015 >7,000 Patients Notified (2 facilities, UT) Nurse 16 patient infected, 2 hospitals 2016 >4,000 Patients Notified (5 facilities, 4 states) Surgical Technician? hospital patients infected 4

5 Signs and Symptoms of Substance Abuse Signs and Symptoms Decline in emotional and physical health Weight gain or loss Picking up extra shifts Not taking vacation Frequent brief absence from work area Overly helpful with medication administration process Pain management discrepancies Behavioral Changes Mood changes Lack of concentration Insomnia/drowsiness Poor judgement Hyperactivity / hypoactivity Frequent lying Defensive if questioned Rideout Health 5

6 Federal Focus on Diversion May 11, 2017 Remarks of Attorney General Jeff Sessions Our country is losing the equivalent of a major league baseball stadium full of people every year to overdoses. That is simply unacceptable. Nearly two thirds of those deaths were from opioids that includes heroin as well as prescription drugs such as oxycodone, hydrocodone, codeine and morphine. Part of DEA s 360 Strategy is diversion control. A lot of drug abuse happens because legitimate controlled substances are diverted from their lawful purposes. We are also targeting and prosecuting dishonest medical providers who violate their oaths by diverting prescription drugs from legitimate uses. The Cost of Diversion 6

7 Federal Enforcement Against Hospitals Dignity Health (July 2014) Diversion of more than 20,000 hydrocodone from outpatient pharmacy Inventory problems and recordkeeping deficiencies $1.5 million penalty Massachusetts General Hospital (September 2015) Over a one year period, two nurses stole approximately 16,000 oxycodone from ADMs. Nurses failed to report suspicions and upon discovery of the theft, MGH failed to notify DEA. DEA audits identified 24,000 missing or extra pills from the inpatient and outpatient pharmacies Multiple recordkeeping violations $2.3 million penalty Northern Maine Medical Center (August 2016) Failure to maintain proper records of controlled substances wasting/disposal $125,000 penalty Rideout Health (October 2016) Expired DEA license Inadequate handling of controlled substances $2.4 million penalty Abington Memorial Hospital (January 2017) Pharmacist at inpatient pharmacy diverted 35,000 units of controlled substances by exploiting gap in pharmacy s monitoring software Recordkeeping violations $510,000 penalty THE GAZETTE DRUG DIVERSION BY HEALTHCARE WORKERS Ex-surgery center employee charged in drug theft March James Edwards, Wayne County District Attorney announced March 2 nd that Karen Feldner, age 56, of Honesdale was arrested and arraigned that day on charges of Theft of Fentanyl, a felony of the third degree and other charges. A large quantity of fentanyl vials were reported stolen from Mountain Laurel Surgery Center in October of Since 1802 In the complaint it is alleged that Feldner stole Fentanyl from the surgical office as an employee, altered documents and forged signatures at the surgical center, obtained Fentanyl through misrepresentation and deception by claiming to have authority from her employer to obtain it when she did not and was in possession of fentanyl. There was a total of 98 vials of Fentanyl that was believed were tampered. Feldner was terminated as a result of her alleged actions. 7

8 Unattended Controlled Substances Managing A Potential Diversion 8

9 Where Do you Start? Implement process for managing a diversion prior to diversion occurring Assess the culture in center Do you have a culture of responsibility around controlled substances? Do you have a culture of reporting? Culture will win over strategy 1 7 Creating a Culture to Support Diversion Prevention Efforts Multidisciplinary approach Commitment to standard processes for monitoring and control Defined accountability and responsibility for monitoring in control Commitment to reporting suspicious behavior for both patient and employee safety reasons Make diversion prevention a priority of the entire facility 18 9

10 Understand Access in the Operating Rooms Evaluate the distribution system What does access look like during and after a case? How does documentation look? Are there orders for the medication Were the medications charted Manual systems much easier to game Evaluate the method for reconciling controlled substances Look for trends and Inconsistency 19 Develop the Diversion Prevention Program Structure Diversion Committee Diversion Response Team Diversion Risk Rounds (unannounced and at least quarterly) 20 10

11 Suspected Diversion Identify investigation lead (communication channel) Multidisciplinary approach Nurse Manager, Medical Director, Administrator VPO, Regional Medical Director, DQRM, Division Pharmacist Evaluate data Tools Video cameras Badge access data Reports Drug Testing Polygraph (?) Report 21 Would Someone Divert This? 11

12 Reporting Diversion Federal Law Federal regulations require that registrants notify the DEA Field Division Office in their area, in writing, of the theft or significant loss of any controlled substance within one business day of discovery of such loss or theft. The registrant shall also complete and submit to the Field Division Office in their area, DEA Form 106, "Report of Theft or Loss of Controlled Substances" regarding the theft or loss. (21 C.F.R (b)) 12

13 Theft All thefts, whether large or small, must be reported to the nearest DEA office upon discovery by utilizing DEA Form 106 Upon discovery is defined as immediately and without delay after realizing there has been a theft or significant loss The DEA views within one business day to be consistent with immediately Local law enforcement as well as state law enforcement should be notified as well as reporting to the state boards (and in some states other agencies) Determining Significant Loss The following factors should be considered when determining if a loss is significant or not: The actual quantity of controlled substances lost in relation to the type of business; The specific controlled substances lost; Whether the loss of the controlled substances can be associated with access to those controlled substances by specific individuals, or whether the loss can be attributed to unique activities that may take place involving the controlled substances; A pattern of losses over a specific time period, whether the losses appear to be random, and the results of efforts taken to resolve the losses; and, if known, Whether the specific controlled substances are likely candidates for diversion; and Local trends and other indicators of the diversion potential of the missing controlled substance US Pharm. 2015;40(12): C.F.R (c) 13

14 Significant Loss Significant losses are required to be reported to the DEA DEA recognizes there is no single objective standard that can be applied to all registrants what constitutes a significant loss for one registrant may be construed as comparatively insignificant for another Any unexplained loss or discrepancy must be reviewed within the context of a registrant's business activity and environment Updated in a 2005 rulemaking discussion to provide guidance on how to determine if something is a loss vs a significant loss Suspicion of Diversion When there is a suspicion of diversion you should report it to MDT Suspicion of diversion can include but is not limited to: Heavy wastage of drugs Excessive amount of time spent near a drug supply Inconsistent or incorrect charting Behaviors consistent with substance use Frequent and unexplained disappearances during shift Obtains larger doses of narcotics when the ordered dose is unavailable and records the excess as waste Pharmacy Purchasing & Products. 2014;11(3):

15 DEA Form 106 Patient Case Nurse manager C receives a call from a local hospital and is informed that PRN Nurse D has been diverting medications and has been caught. PRN Nurse D calls Nurse manager C to let him know that she is entering a treatment program. PRN Nurse D tells Nurse manager C that she has never diverted medications from the surgery center. What should Nurse manager C do? a. Immediately notify leadership/mdt b. Review PRN Nurse D activities during monthly review to confirm report of not diverting c. Nothing, PRN Nurse D said they had not diverted any medications 15

16 Patient Case (Answer) Nurse manager C receives a call from a local hospital and is informed that PRN Nurse D has been diverting medications and has been caught. PRN Nurse D calls Nurse manager C to let him know that she is entering a treatment program. PRN Nurse D tells Nurse manager C that she has never diverted medications from this surgery center. What should Nurse manager C do? a. Immediately notify leadership/mdt b. Review PRN Nurse D activities during monthly review to confirm report of not diverting c. Nothing, PRN Nurse D said they had not diverted any medications Any time an employee has been found to be diverting at another facility, the MDT should be notified and conduct a thorough investigation of the case

17 Unattended Unlabeled Controlled Substances If you are having surgery, do you want this syringe of fentayl that has been left unattended administered to you? 17

18 Summary Sub headline Pervasive social problem Healthcare professionals not immune Creates serious patient safety concern Exposes organizations to legal and regulatory sanctions Requires constant vigilance Multidisciplinary organizational commitment to a culture of responsibility THANK YOU! 18

Medication Diversion and Prescription Drug Abuse in the Long Term Care Setting. Objectives

Medication Diversion and Prescription Drug Abuse in the Long Term Care Setting. Objectives Medication Diversion and Prescription Drug Abuse in the Long Term Care Setting Objectives Discuss: Learn about signs of potential diversion and recognize an impaired healthcare provider. Help to identify

More information

Understanding Diversion in the Pharmacy Kimberly S. New JD BSN RN

Understanding Diversion in the Pharmacy Kimberly S. New JD BSN RN Understanding Diversion in the Pharmacy Kimberly S. New JD BSN RN All Rights Reserved Scope of the Problem Diversion can t be prevented entirely Substantial safety, quality, regulatory and legal risk Mitigate

More information

AHLA. T. Diversion of Controlled Substance in Health Care Setting

AHLA. T. Diversion of Controlled Substance in Health Care Setting AHLA T. Diversion of Controlled Substance in Health Care Setting Lorri Hall Abramowitz Drug Diversion Specialist UF Health Jacksonville Jacksonville, FL Ann M. Bittinger The Bittinger Law Firm Jacksonville,

More information

10/4/12. Controlled Substances Dispensing Issues and Solutions. Objectives. Financial Disclosure

10/4/12. Controlled Substances Dispensing Issues and Solutions. Objectives. Financial Disclosure Controlled Substances Dispensing Issues and Solutions Ronald W. Buzzeo, R.Ph. Chief Compliance Officer November 7, 2012 CE Code: Financial Disclosure I have no actual or potentially relevant financial

More information

Data Analytics In Healthcare Diversion Prevention, Detection and Response Quality Improvement

Data Analytics In Healthcare Diversion Prevention, Detection and Response Quality Improvement Data Analytics In Healthcare Diversion Prevention, Detection and Response Quality Improvement This presentation will cover The Wake-up call How we incorporated data analytics into our diversion detection

More information

Understanding Diversion

Understanding Diversion Drug Diversion Prevention, Detection and Response Programs: Essential Knowledge for the Healthcare Professional John Burke, President, IHFDA Kimberly New, Executive Director, IHFDA 2016 All Rights Reserved

More information

Scope of the Problem. Leadership Engagement. Leadership Engagement. Risk of Harm to Patients. Risk of Harm to Patients 6/13/2016

Scope of the Problem. Leadership Engagement. Leadership Engagement. Risk of Harm to Patients. Risk of Harm to Patients 6/13/2016 Protecting Patients from Harm: Establishing an Institutional Diversion Program Kimberly S. New JD BSN RN Scope of the Problem All facilities face this issue Diversion can t be prevented entirely Substantial

More information

REGULATION MARKUP REGULATION NO. 2

REGULATION MARKUP REGULATION NO. 2 REGULATION MARKUP REGULATION NO. 2 The Arkansas Medical Practices Act authorizes the Arkansas State Medical Board to revoke or suspend the license issued by the Board to practice medicine if the holder

More information

A Million Little Pieces: Developing a Controlled Substance Diversion Program. Tanya Y. Barnhart, PharmD, BCPS

A Million Little Pieces: Developing a Controlled Substance Diversion Program. Tanya Y. Barnhart, PharmD, BCPS A Million Little Pieces: Developing a Controlled Substance Diversion Program Tanya Y. Barnhart, PharmD, BCPS I have no conflicts of interest to disclose Objectives Explain the importance of building a

More information

Pharmaceutical Diversion Prevention, Detection and Incident Response

Pharmaceutical Diversion Prevention, Detection and Incident Response Pharmaceutical Diversion Prevention, Detection and Incident Response HIPAA Security Officer, Mount Sinai Health System President, Society of Professional Investigators Associate Director of Administration

More information

3. Practicing fraud, deceit, or misrepresentation in the practice of medicine.

3. Practicing fraud, deceit, or misrepresentation in the practice of medicine. REGULATION MARKUP REGULATION NO. 2 The Arkansas Medical Practices Act authorizes the Arkansas State Medical Board to revoke or suspend the license issued by the Board to practice medicine if the holder

More information

Drug Diversion Prevention The Mayo Clinic Experience

Drug Diversion Prevention The Mayo Clinic Experience Drug Diversion Prevention The Mayo Clinic Experience Kevin R. Dillon, Pharm.D., MPH Director of Pharmacy Services Mayo Clinic Health Care Compliance Association Upper Midwest - Regional Annual Conference

More information

Drug Diversion Exercise. New Jersey Department of Health Pilot Project-Safe Injection Practices January/February 2016

Drug Diversion Exercise. New Jersey Department of Health Pilot Project-Safe Injection Practices January/February 2016 Drug Diversion Exercise New Jersey Department of Health Pilot Project-Safe Injection Practices January/February 2016 What is Drug Diversion When prescription medicines are obtained or used illegally This

More information

Not if, but When: Drug Diversion in Hospitals. Christopher Fortier, PharmD, FASHP Chief Pharmacy Officer Massachusetts General Hospital Boston, MA

Not if, but When: Drug Diversion in Hospitals. Christopher Fortier, PharmD, FASHP Chief Pharmacy Officer Massachusetts General Hospital Boston, MA Not if, but When: Drug Diversion in Hospitals Christopher Fortier, PharmD, FASHP Chief Pharmacy Officer Massachusetts General Hospital Boston, MA Healthcare workers 100,000 annually 1 in 10 Affects people

More information

Patient Safety. Road Map to Controlled Substance Diversion Prevention

Patient Safety. Road Map to Controlled Substance Diversion Prevention Patient Safety Road Map to Controlled Substance Diversion Prevention Road Map to Diversion Prevention safe S Safety Teams/ Organizational Structure A Access to information/ Accurate Reporting/ Monitoring/

More information

It s every OR manager s nightmare a drug diversion that hits the local

It s every OR manager s nightmare a drug diversion that hits the local Substance abuse Drug diversion in the OR: How can you keep it from happening? It s every OR manager s nightmare a drug diversion that hits the local news. That nightmare came true for 2 Colorado facilities

More information

An Interview With. Thomas P. Lenox. Supervisory Special Agent, Drug Enforcement Administration. Interview by Roneet Lev, MD

An Interview With. Thomas P. Lenox. Supervisory Special Agent, Drug Enforcement Administration. Interview by Roneet Lev, MD An Interview With Thomas P. Lenox Supervisory Special Agent, Drug Enforcement Administration Interview by Roneet Lev, MD 24 april 2013 DPart 1 Dr. Lev: First of all, thank you for agreeing to be in San

More information

POSITION STATEMENT. - desires to protect the public from students who are chemically impaired.

POSITION STATEMENT. - desires to protect the public from students who are chemically impaired. Page 1 of 18 POSITION STATEMENT The School of Pharmacy and Health Professions: - desires to protect the public from students who are chemically impaired. - recognizes that chemical impairment (including

More information

District of Columbia Prescription Drug Monitoring Program

District of Columbia Prescription Drug Monitoring Program District of Columbia Prescription Drug Monitoring Program What Our Users Need to Know Health Regulation and Licensing Administration Pharmaceutical Control Division February 28, 2017 1 Mission Statement

More information

SECTION 1: PROCESS FOR NEW/ANNUAL RENEWAL OF MED AGREEMENT:

SECTION 1: PROCESS FOR NEW/ANNUAL RENEWAL OF MED AGREEMENT: Clinic Name Medication Agreement Process Effective Version #: Document #: Next Review: Page 1 of 8 SCOPE: Medication Agreement Process PURPOSE: Define the steps, parameters, and team responsibilities for

More information

POLICIES, PENALTIES AND PROCEDURES

POLICIES, PENALTIES AND PROCEDURES POLICIES, PENALTIES AND PROCEDURES Policies exist to eliminate confusion and define for all people involved how things will be done in our practice. That way there is no misunderstanding and no perception

More information

247 CMR: BOARD OF REGISTRATION IN PHARMACY

247 CMR: BOARD OF REGISTRATION IN PHARMACY 247 CMR 9.00: CODE OF PROFESSIONAL CONDUCT; PROFESSIONAL STANDARDS FOR REGISTERED PHARMACISTS, PHARMACIES AND PHARMACY DEPART- MENTS Section 9.01: Code of Professional Conduct for Registered Pharmacists,

More information

Prepared for the Foundation of the American College of Healthcare Executives Session 101AB Not If, but When: Drug Diversion in Hospitals

Prepared for the Foundation of the American College of Healthcare Executives Session 101AB Not If, but When: Drug Diversion in Hospitals Prepared for the Foundation of the American College of Healthcare Executives Session 101AB Not If, but When: Drug Diversion in Hospitals Presented by: Christopher Fortier, PharmD Not if, but When: Drug

More information

2015 Annual Convention

2015 Annual Convention 2015 Annual Convention Date: Tuesday, October 13, 2015 Time: 9:45 am 11:15 am Location: Gaylord National Harbor Resort and Convention Center, National Harbor 10 Title: Activity Type: Speaker: How to Be

More information

Kimberly S. New RN BSN JD Compliance Specialist University of Tennessee Medical Center

Kimberly S. New RN BSN JD Compliance Specialist University of Tennessee Medical Center 1 Institutional Drug Diversion Kimberly S. New RN BSN JD Compliance Specialist University of Tennessee Medical Center AHIA 31 st Annual Conference August 26-29, 2012 Philadelphia PA www.ahia.org Discussion

More information

NEW MEXICO PRACTITIONER S MANUAL

NEW MEXICO PRACTITIONER S MANUAL NEW MEXICO PRACTITIONER S MANUAL An Informational Outline From the New Mexico Board of Pharmacy 5200 Oakland NE Suite A Albuquerque, New Mexico 87113 505-222-9830 800-565-9102 E-Mail: Debra.wilhite@state.nm.us

More information

Frequently Asked Questions

Frequently Asked Questions 1. What is dispensing? Frequently Asked Questions DO I NEED A PERMIT? Dispensing means the procedure which results in the receipt of a prescription drug by a patient. Dispensing includes: a. Interpretation

More information

NATIONAL ASSOCIATION FOR STATE CONTROLLED SUBSTANCES AUTHORITIES (NASCSA) MODEL PRESCRIPTION MONITORING PROGRAM (PMP) ACT (2016) COMMENT

NATIONAL ASSOCIATION FOR STATE CONTROLLED SUBSTANCES AUTHORITIES (NASCSA) MODEL PRESCRIPTION MONITORING PROGRAM (PMP) ACT (2016) COMMENT 1 NATIONAL ASSOCIATION FOR STATE CONTROLLED SUBSTANCES AUTHORITIES (NASCSA) MODEL PRESCRIPTION MONITORING PROGRAM (PMP) ACT (2016) SECTION 1. SHORT TITLE. This Act shall be known and may be cited as the

More information

Development of a Road Map to Controlled Substance Diversion Prevention

Development of a Road Map to Controlled Substance Diversion Prevention Development of a Road Map to Controlled Substance Diversion Prevention Rene Cronquist, RN, J.D. Director of Practice and Policy Minnesota Board of Nursing In the news. Prison Sought for Nurse Who Stole

More information

PREPARATION AND ADMINISTRATION

PREPARATION AND ADMINISTRATION LESSON PLAN: 12 COURSE TITLE: UNIT: IV MEDICATION TECHNICIAN PREPARATION AND ADMINISTRATION SCOPE OF UNIT: Guidelines and procedures for preparation, administration, reporting, and recording of oral, ophthalmic,

More information

RULES OF THE TENNESSEE BOARD OF NURSING CHAPTER ADVANCED PRACTICE NURSES & CERTIFICATES OF FITNESS TO PRESCRIBE TABLE OF CONTENTS

RULES OF THE TENNESSEE BOARD OF NURSING CHAPTER ADVANCED PRACTICE NURSES & CERTIFICATES OF FITNESS TO PRESCRIBE TABLE OF CONTENTS RULES OF THE TENNESSEE BOARD OF NURSING CHAPTER 1000-04 ADVANCED PRACTICE NURSES & CERTIFICATES TABLE OF CONTENTS 1000-04-.01 Purpose and Scope 1000-04-.07 Processing of Applications 1000-04-.02 Definitions

More information

DRUG DIVERSION PREVENTION

DRUG DIVERSION PREVENTION DRUG DIVERSION PREVENTION in Healthcare Kimberly New, BSN, JD, RN Drug Diversion in Healthcare Kimberly New, BSN, JD, RN Drug Diversion in Healthcare is published by HCPro, a division of BLR. Copyright

More information

National Association of Boards of Pharmacy PMP Interconnect NABP

National Association of Boards of Pharmacy PMP Interconnect NABP National Association of Boards of Pharmacy PMP Interconnect NABP Problems with PMPs: Persons engaging in doctor shopping don t stay in one state, particularly areas that border other states Querying the

More information

Applicable State Licensing Requirements for Combined Federal and Comprehensive HHA Survey

Applicable State Licensing Requirements for Combined Federal and Comprehensive HHA Survey Applicable State Licensing Requirements for Combined Federal and Comprehensive HHA Survey Statute 144A.44 HOME CARE BILL OF RIGHTS Subdivision 1. Statement of rights. A person who receives home care services

More information

HB 1 Regulations Board of Medical Licensure

HB 1 Regulations Board of Medical Licensure HB 1 Regulations Board of Medical Licensure C. Lloyd Vest II, J.D. General Counsel Kentucky Board of Medical Licensure Faculty Disclosure I have not had any relevant financial relationships during the

More information

Frequently Asked Questions

Frequently Asked Questions 450 Simmons Way #700, Kaysville, UT 84037 (801) 547-9947 unar@davistech.edu www.utahcna.com Frequently Asked Questions UNAR stands for the Utah Nursing Assistant Registry, the agency in charge of the registry

More information

PRESCRIPTION MONITORING PROGRAM STATE PROFILES TENNESSEE

PRESCRIPTION MONITORING PROGRAM STATE PROFILES TENNESSEE PRESCRIPTION MONITORING PROGRAM STATE PROFILES TENNESSEE Research current through July 2014. This project was supported by Grant No. G1399ONDCP03A, awarded by the Office of National Drug Control Policy.

More information

9/15/2017. Nursing: Substance Use, Drug Diversion, and Recovery Nancy Rogers, MS, RN-BC, CASAC, CNE. Objectives. Substance Use Among Nurses

9/15/2017. Nursing: Substance Use, Drug Diversion, and Recovery Nancy Rogers, MS, RN-BC, CASAC, CNE. Objectives. Substance Use Among Nurses Nursing: Substance Use, Drug Diversion, and Recovery Nancy Rogers, MS, RN-BC, CASAC, CNE Objectives Participants will be able to discuss the warning signs of an impaired nurse Participants will be able

More information

Healthcare Facility Drug Diversion: America s Best Kept Secret. Kimberly S. New JD BSN RN

Healthcare Facility Drug Diversion: America s Best Kept Secret. Kimberly S. New JD BSN RN Healthcare Facility Drug Diversion: America s Best Kept Secret Kimberly S. New JD BSN RN Discussion Points Scope of the problem Reporting requirements Profile and predisposing factors Impact on the patient

More information

How to Detect and Prevent Drug Diversion - Lessons from an Academic Medical Center. Session Objectives

How to Detect and Prevent Drug Diversion - Lessons from an Academic Medical Center. Session Objectives How to Detect and Prevent Drug Diversion - Lessons from an Academic Medical Center Presenters Tim Marshall, Director, Oregon Health & Science University Meaghan Smith, Lead Auditor, Oregon Health & Science

More information

RALF Behavior Management Rules IDAPA

RALF Behavior Management Rules IDAPA RALF Behavior Management Rules IDAPA 16.03.22 DEFINITIONS: 010.10. Assessment. The conclusion reached using uniform criteria which identifies resident strengths, weaknesses, risks and needs, to include

More information

Medication Assisted Treatment for Opioid Use Disorders Reporting Requirements

Medication Assisted Treatment for Opioid Use Disorders Reporting Requirements This document is scheduled to be published in the Federal Register on 09/27/2016 and available online at https://federalregister.gov/d/2016-23277, and on FDsys.gov DEPARTMENT OF HEALTH AND HUMAN SERVICES

More information

ROUND LAKE Journey Toward Healthy. Treatment Centre

ROUND LAKE Journey Toward Healthy. Treatment Centre ROUND LAKE Treatment Centre Culture is Treatment HARM REDUCTION HARM REDUCTION Photo Credits: Carla Hunt HARM REDUCTION WELLNESS IS A JOURNEY NOT A DESTINATION (FNHA) OPIOID AGONIST THERAPY METHADONE SUBOXONE

More information

Pharmaceutical Services Instructor s Guide CFR , (a)(b)(1) F425

Pharmaceutical Services Instructor s Guide CFR , (a)(b)(1) F425 Centers for Medicare & Medicaid Services (CMS) Pharmaceutical Services Instructor s Guide CFR 483.60, 483.60(a)(b)(1) F425 2006 Prepared by: American Institutes for Research 1000 Thomas Jefferson St, NW

More information

BEFORE THE NORTH CAROLINA MEDICAL BOARD ) ) ) ) ) This matter is before the North Carolina Medical Board

BEFORE THE NORTH CAROLINA MEDICAL BOARD ) ) ) ) ) This matter is before the North Carolina Medical Board BEFORE THE NORTH CAROLINA MEDICAL BOARD In re: Timothy John Phillips, PA-C, Respondent. CONSENT ORDER This matter is before the North Carolina Medical Board ( Board regarding information provided to the

More information

PRESCRIBING IN NEVADA

PRESCRIBING IN NEVADA PRESCRIBING IN NEVADA An Inside Look at Changes to Nevada Laws Surrounding Prescribing Controlled Substances for the Treatment of Pain These changes to Nevada law do not impact the authority of practitioners

More information

Definitions: In this chapter, unless the context or subject matter otherwise requires:

Definitions: In this chapter, unless the context or subject matter otherwise requires: CHAPTER 61-02-01 Final Copy PHARMACY PERMITS Section 61-02-01-01 Permit Required 61-02-01-02 Application for Permit 61-02-01-03 Pharmaceutical Compounding Standards 61-02-01-04 Permit Not Transferable

More information

Advanced Practice Nurses Authority to Diagnose and Prescribe. Excellence Through Coordinated Patient Care. Copyright protected. information.

Advanced Practice Nurses Authority to Diagnose and Prescribe. Excellence Through Coordinated Patient Care. Copyright protected. information. Excellence Through Coordinated Patient Care Copyright protected information. Provided courtesy of the Illinois State Medical Society Advanced Practice Nurses Authority to Diagnose and Prescribe 12-1655-S

More information

Drug Diversion Tabletop Exercise for Ambulatory Surgery Centers (ASCs) Facilitator Guide with Scenarios

Drug Diversion Tabletop Exercise for Ambulatory Surgery Centers (ASCs) Facilitator Guide with Scenarios Drug Diversion Tabletop Exercise for Ambulatory Surgery Centers (ASCs) Facilitator Guide with Scenarios Overview The New Jersey Department of Health (NJDOH) created a tabletop exercise for Ambulatory Surgery

More information

(b) Is administered via a transdermal route; or

(b) Is administered via a transdermal route; or ACTION: To Be Refiled DATE: 10/10/2018 2:31 PM 4723-9-10 Formulary; standards of prescribing for advanced practice registered nurses designated as clinical nurse specialists, certified nurse-midwives,

More information

The CMS State Operations Manual Overview and Changes

The CMS State Operations Manual Overview and Changes The CMS State Operations Manual Overview and Changes Omnicare, Inc. Page 1 Overview of the CMS State Operations Manual Executive Summary Historical Perspective The Requirements Pharmacy Services Labeling

More information

483.45(b) Service Consultation. The facility must employ or obtain the services of a licensed pharmacist who

483.45(b) Service Consultation. The facility must employ or obtain the services of a licensed pharmacist who F755 483.45 Pharmacy Services The facility must provide routine and emergency drugs and biologicals to its residents, or obtain them under an agreement described in 483.70(g). The facility may permit unlicensed

More information

On September 4, 2012, the evening shift supervisor called the

On September 4, 2012, the evening shift supervisor called the Case-in-Point Investigating and Making a Case for Drug Diversion Donna H. Mooney, MBA, RN One of the biggest challenges facing boards of nursing (BONs) is ensuring that a fair disciplinary process occurs

More information

GENERAL ASSEMBLY OF NORTH CAROLINA SESSION 2017 S 2 SENATE BILL 750* Health Care Committee Substitute Adopted 6/12/18

GENERAL ASSEMBLY OF NORTH CAROLINA SESSION 2017 S 2 SENATE BILL 750* Health Care Committee Substitute Adopted 6/12/18 GENERAL ASSEMBLY OF NORTH CAROLINA SESSION 0 S SENATE BILL 0* Health Care Committee Substitute Adopted /1/ Short Title: Health-Local Confinement/Vet. Controlled Sub. (Public) Sponsors: Referred to: May,

More information

CONSULTANT PHARMACIST INSPECTION LAW REVIEW

CONSULTANT PHARMACIST INSPECTION LAW REVIEW CONSULTANT PHARMACIST LAW REVIEW Florida Consultant Pharmacist s are required in: a. Class I Institutional Pharmacies b. Class II Institutional Pharmacies c. Modified Class II Institutional Pharm. d. Assisted

More information

Eau Claire County Mental Health Court. Presentation December 15, 2011

Eau Claire County Mental Health Court. Presentation December 15, 2011 Eau Claire County Mental Health Court Presentation December 15, 2011 Collaboration State & County Government Eau Claire County Mental Health & Jail Diversion Task Force First Brought State & County Agencies

More information

ALABAMA BOARD OF MEDICAL EXAMINERS ADMINISTRATIVE CODE CHAPTER 540-X-19 PAIN MANAGEMENT SEVICES TABLE OF CONTENTS

ALABAMA BOARD OF MEDICAL EXAMINERS ADMINISTRATIVE CODE CHAPTER 540-X-19 PAIN MANAGEMENT SEVICES TABLE OF CONTENTS Medical Examiners Chapter 540-X-19 ALABAMA BOARD OF MEDICAL EXAMINERS ADMINISTRATIVE CODE CHAPTER 540-X-19 PAIN MANAGEMENT SEVICES TABLE OF CONTENTS 540-X-19-.01 540-X-19-.02 540-X-19-.03 540-X-19-.04

More information

Bold blue=new language Red strikethrough=deleted language Regular text=existing language Bold Green = new changes following public hearing

Bold blue=new language Red strikethrough=deleted language Regular text=existing language Bold Green = new changes following public hearing Bold blue=new language Red strikethrough=deleted language Regular text=existing language Bold Green = new changes following public hearing 700.001: Definitions Delegate means an authorized support staff

More information

Robert J. Walters, Senior Assistant Attorney General Wyoming Attorney General s Office June 5, 2014

Robert J. Walters, Senior Assistant Attorney General Wyoming Attorney General s Office June 5, 2014 Robert J. Walters, Senior Assistant Attorney General Wyoming Attorney General s Office June 5, 2014 Introduction : Introduction The prescription drug abuser, or drug seeker, represents a serious and constant

More information

Prescription Drug Monitoring Program (PDMP)

Prescription Drug Monitoring Program (PDMP) Prescription Drug Monitoring Program (PDMP) New Jersey Information contained in this presentation is accurate as of September 2017 Meet the Speaker Sindy Paul, MD, MPH, FACPM Medical Director - NJ Board

More information

Assessment. SMP Foundations Training Kit. Table of Contents

Assessment. SMP Foundations Training Kit. Table of Contents SMP Foundations Training Kit Assessment Table of Contents Participant Assessment Questions and Answer Form Assessment Questions... 10 Pages Answer Form... 2 Pages Trainer s Resources Answer Key... 2 Pages

More information

APPROVED REGULATION OF THE STATE BOARD OF PHARMACY. LCB File No. R Effective May 16, 2018

APPROVED REGULATION OF THE STATE BOARD OF PHARMACY. LCB File No. R Effective May 16, 2018 APPROVED REGULATION OF THE STATE BOARD OF PHARMACY LCB File No. R015-18 Effective May 16, 2018 EXPLANATION Matter in italics is new; matter in brackets [omitted material] is material to be omitted. AUTHORITY:

More information

STATE OF MICHIGAN DEPARTMENT OF LICENSING AND REGULATORY AFFAIRS BUREAU OF PROFESSIONAL LICENSING BOARD OF PHARMACY DISCIPLINARY SUBCOMMITTEE

STATE OF MICHIGAN DEPARTMENT OF LICENSING AND REGULATORY AFFAIRS BUREAU OF PROFESSIONAL LICENSING BOARD OF PHARMACY DISCIPLINARY SUBCOMMITTEE In the Matter of STATE OF MICHIGAN DEPARTMENT OF LICENSING AND REGULATORY AFFAIRS BUREAU OF PROFESSIONAL LICENSING BOARD OF PHARMACY DISCIPLINARY SUBCOMMITTEE ANGEL A. OJEDA, M.D. Controlled Substance

More information

Mandatory Reporting Requirements: The Elderly Rhode Island

Mandatory Reporting Requirements: The Elderly Rhode Island Mandatory Reporting Requirements: The Elderly Rhode Island Question Who is required to report? When is a report required and where does it go? Answer Any person. Any physician, medical intern, registered

More information

Preventing Medical Errors

Preventing Medical Errors Presents Preventing Medical Errors Contact Hours: 2 First Published: March 31, 2017 This Course Expires on: March 31, 2019 Course Objectives Upon completion of this course, the nurse will be able to: 1.

More information

Medication Reconciliation Review

Medication Reconciliation Review The Medication Reconciliation Review tool provides step-by-step instructions for conducting a review of closed patient records to identify errors related to unreconciled medications. Organizations that

More information

Welcome to Nevada Neurosurgery:

Welcome to Nevada Neurosurgery: Welcome to Nevada Neurosurgery: Nevada Neurosurgery offers the complete care of surgical and nonsurgical cranial and spinal disorders ranging from degenerative disc disease to cervical and lumbar spine

More information

RULES and REGULATIONS: PRESCRIBING CONTROLLED SUBSTANCES IN MS. Mississippi State Board of Medical Licensure June 24, 2016 Thomas Washington, CMBI

RULES and REGULATIONS: PRESCRIBING CONTROLLED SUBSTANCES IN MS. Mississippi State Board of Medical Licensure June 24, 2016 Thomas Washington, CMBI RULES and REGULATIONS: PRESCRIBING CONTROLLED SUBSTANCES IN MS. Mississippi State Board of Medical Licensure June 24, 2016 Thomas Washington, CMBI This agency was created as an independent state agency

More information

Storage, Labeling, Controlled Medications Instructor s Guide CFR (b)(2)(3)(d)(e) F431

Storage, Labeling, Controlled Medications Instructor s Guide CFR (b)(2)(3)(d)(e) F431 Centers for Medicare & Medicaid Services (CMS) Storage, Labeling, Controlled Medications Instructor s Guide CFR 483.60(b)(2)(3)(d)(e) F431 2006 Prepared by: American Institutes for Research 1000 Thomas

More information

(7) Indicate the appropriate and explicit directions for use. (9) Not authorize any refills for schedule II controlled substances.

(7) Indicate the appropriate and explicit directions for use. (9) Not authorize any refills for schedule II controlled substances. ACTION: Revised DATE: 07/20/2017 4:25 PM 4729-5-30 Manner of issuance of a prescription. (A) A prescription, to be valid, must be issued for a legitimate medical purpose by an individual prescriber acting

More information

DC Board of Pharmacy and Pharmaceutical Control Update

DC Board of Pharmacy and Pharmaceutical Control Update DC Board of Pharmacy and Pharmaceutical Control Update Patricia M. D Antonio, RPh, MS, MBA,CGP Executive Director, Board of Pharmacy Program Manager, Pharmaceutical Control May 30, 2015 Organization Health

More information

DC Board of Pharmacy and Pharmaceutical Control Update

DC Board of Pharmacy and Pharmaceutical Control Update DC Board of Pharmacy and Pharmaceutical Control Update Shauna K. White, Pharm.D, MS Executive Director Board of Pharmacy Program Manager - Pharmaceutical Control Division September 17, 2016 Objectives

More information

Prescribing Controlled Drugs: Standard Operating Procedure

Prescribing Controlled Drugs: Standard Operating Procedure Clinical Prescribing Controlled Drugs: Standard Operating Procedure Document Control Summary Status: Version: Author/Owner/Title: Approved by: Ratified: Related Trust Strategy and/or Strategic Aims Implementation

More information

Social care guideline Published: 14 March 2014 nice.org.uk/guidance/sc1

Social care guideline Published: 14 March 2014 nice.org.uk/guidance/sc1 Managing medicines in care homes Social care guideline Published: 14 March 2014 nice.org.uk/guidance/sc1 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).

More information

Advanced Practice Nurse Authority to Diagnose and Prescribe

Advanced Practice Nurse Authority to Diagnose and Prescribe Advanced Practice Nurse Authority to Diagnose and Prescribe Copyright protected information. Provided courtesy of the Illinois State Medical Society ADVANCED PRACTICE NURSES AUTHORITY TO DIAGNOSE AND PRESCRIBE

More information

Please accurately complete the entire application. No action will be taken on applications with missing information.

Please accurately complete the entire application. No action will be taken on applications with missing information. 2508 E. Fox Farm Road, 1-1A Cheyenne, WY 82007 (307) 635-3618 Fax: (307) 635-1442 www.wyhealthworks.org Application for Employment (HealthWorks does not discriminate based on color, creed, religion, national

More information

Compliance Made Simple: 24/7/365

Compliance Made Simple: 24/7/365 9/27/13 A webinar series that keeps you in the know Brought to you by Progressive Compliance Made Simple: 24/7/365 ì Crissy Benze, RN, BSN Progressive Huddle September 30, 2013 Objectives Know what to

More information

Prescription Monitoring Program NL. Information for Prescribers and Dispensers

Prescription Monitoring Program NL. Information for Prescribers and Dispensers Prescription Monitoring Program NL Information for Prescribers and Dispensers Frequently sked uestions and nswers Prescription Monitoring Program NL supports the Provincial Government s Opioid ction Plan

More information

Structured Practical Experiential Program

Structured Practical Experiential Program 2017/18 Structured Practical Experiential Program PHARMACY STUDENT AND INTERN ROTATIONS RESOURCE COLLEGE OF PHARMACISTS OF MANITOBA COLLEGE OF PHARMACY RADY FACULTY OF HEALTH SCIENCES UNIVERSITY OF MANITOBA

More information

Prescription Drug Monitoring Program (PDMP)

Prescription Drug Monitoring Program (PDMP) Prescription Drug Monitoring Program (PDMP) New York State Information contained in this presentation is accurate as of September 2017 Meet the Speaker Anita Murray, R.Ph., Deputy Director Bureau of Narcotic

More information

E-Forum. Election Results. Board Members and Officers. Message from the President. Upcoming Board Meetings. Inside this issue:

E-Forum. Election Results. Board Members and Officers. Message from the President. Upcoming Board Meetings. Inside this issue: North Carolina State Board of Dental Examiners E-Forum Volume 4, Issue 3 June-August 2017 Election Results Thanks to all who voted in the recent Dental Board election and run-off election. When all votes

More information

SafetyFirst Alert. Improving Prescription/Order Writing. Illegible handwriting

SafetyFirst Alert. Improving Prescription/Order Writing. Illegible handwriting SafetyFirst Alert Massachusetts Coalition for the Prevention of Medical Errors January 2000 This issue of Safety First Alert is a publication of the Massachusetts Coalition for the Prevention of Medical

More information

1) ELIGIBLE DISCIPLINES

1) ELIGIBLE DISCIPLINES PRACTITIONER S APPLICABLE TO ALL INDIVIDUAL NETWORK PARTICIPANTS AND APPLICANTS FOR THE PREFERRED PAYMENT PLAN NETWORK, MEDI-PAK ADVANTAGE PFFS NETWORK AND MEDI-PAK ADVANTAGE LPPO NETWORK of Arkansas Blue

More information

PHARMACY RULES COMMITTEE of the PHARMACY EXAMINING BOARD

PHARMACY RULES COMMITTEE of the PHARMACY EXAMINING BOARD Wisconsin Department of Safety and Professional Services Division of Policy Development 1400 E. Washington Ave PO Box 8366 Madison WI 53708-8366 Phone: 608-266-2112 Web: http://dsps.wi.gov Email: dsps@wisconsin.gov

More information

THE BASICS THE BASICS STAFF EDUCATION DRUG DIVERSION TASK FORCE 4/8/2016. MSHP Annual Meeting 2016

THE BASICS THE BASICS STAFF EDUCATION DRUG DIVERSION TASK FORCE 4/8/2016. MSHP Annual Meeting 2016 /8/01 MSHP Annual Meeting 01 DEA Audit and Investigation Lessons Learned: Training, Reporting, Surveillance, Auditing and Technology Erasmo (Ray) Mitrano, RPh, MS, Senior Director Controlled Substance

More information

2016 Plan of Correction Data 1

2016 Plan of Correction Data 1 2016 Plan of Correction Data 1 Retail Data Calendar Year 2015 2016 Number of Inspections 1263 1694 number of Plan of Correction s (POC s) issued 502 523 Regulatory Citations 2 & 2015 2016 number of POC

More information

MEDCOM Medication Management Discussion

MEDCOM Medication Management Discussion MEDCOM Medication Management Discussion 2009 MEDCOM-TJC Conference Manager, Army Patient Safety Program Quality Management Office HQ, US Army Medical Command Fort Sam Houston, TX 19 Nov 2009 BRIEFING OUTLINE

More information

Pharmaceutical Services Requirements: formerly 10D and 10C.7

Pharmaceutical Services Requirements: formerly 10D and 10C.7 Pharmaceutical Services Requirements: formerly 10D.28-29 and 10C.7 Frank S. Emanuel, Pharm.D., FASHP Associate Professor/Division Director Florida A and M University College of Pharmacy Jacksonville Disclosure

More information

Frequently Asked Questions MN Prescription Monitoring Program (PMP)

Frequently Asked Questions MN Prescription Monitoring Program (PMP) Frequently Asked Questions MN Prescription Monitoring Program (PMP) Topics: 1. Purpose of the PMP 2. Reporting/Frequency of Reporting 3. Dispensing for Animals 4. Inappropriate Prescribing 5. Accessing

More information

THE GENERAL ASSEMBLY OF PENNSYLVANIA SENATE BILL AN ACT

THE GENERAL ASSEMBLY OF PENNSYLVANIA SENATE BILL AN ACT PRINTER'S NO. THE GENERAL ASSEMBLY OF PENNSYLVANIA SENATE BILL No. INTRODUCED BY LEACH AND FERLO, JUNE, REFERRED TO JUDICIARY, JUNE, Session of AN ACT 1 1 1 1 Amending Title (Decedents, Estates and Fiduciaries)

More information

Policy for Anticipatory Prescribing and Just in Case Bags

Policy for Anticipatory Prescribing and Just in Case Bags Policy for Anticipatory Prescribing and Just in Case Bags This policy was developed by Milton Keynes End of Life Care Medicine Group and has been adopted by all partner organisations (MK Clinical Commissioning

More information

Drug Diversion: Enforcement Trends, Investigation, & Prevention

Drug Diversion: Enforcement Trends, Investigation, & Prevention Drug Diversion: Enforcement Trends, Investigation, & Prevention REGINA F. GURVICH, MBA, CHC, CHPC Agenda Definitions, causes, and sources Regulations and enforcement trends Role of the Compliance Officer

More information

Medical History Form

Medical History Form Medical History Form Patient Name of Birth Medical History Do you have or have you had any of the following? Condition Yes No Condition Yes No Condition Yes No ADHD Stroke Menopausal Syndrome Allergies

More information

Purpose This procedure provides guidance on the use and documentation of Controlled Medications

Purpose This procedure provides guidance on the use and documentation of Controlled Medications Controlled Medications HELI.CLI.20 Purpose This procedure provides guidance on the use and documentation of Controlled Medications For Review Aug 2015 1. Introduction 2. Definitions Aeromedical Retrieval

More information

2201 Murphy Avenue, Suite 307 Nashville, TN Phone Fax Date. Patient s Full Name

2201 Murphy Avenue, Suite 307 Nashville, TN Phone Fax Date. Patient s Full Name Patient Information 2201 Murphy Avenue, Suite 307 Nashville, TN 37203 Phone 615-401- 9454 Fax 615-873- 1934 www.robbinsplasticsurgery.com Date Patient s Full Name Last First M.I. Preferred Name (if different

More information

Disclosures. Learning Objectives. Pharmacy Law Topics. Spring Seminar 2017

Disclosures. Learning Objectives. Pharmacy Law Topics. Spring Seminar 2017 Spring Seminar 2017 prescribing authority Controlled substance Privacy Pharmacy Law Topics Charlie Mollien, PharmD, JD, MS Director of Pharmacy Compliance & Privacy Officer Meijer Disclosures Charlie Mollien

More information

Regulations. The regulations which require and govern reports to DBHDS which could be reported in the CHRIS system are:

Regulations. The regulations which require and govern reports to DBHDS which could be reported in the CHRIS system are: CHRIS Reporting: There are a number of issues and concerns which have been raised about the requirements of the CHRIS reporting system. We are not going to attempt to address the technical issues with

More information

Appendix A: Requirements and Best Practices for Reportable Incidents

Appendix A: Requirements and Best Practices for Reportable Incidents Appendix A: Requirements and Best Practices for Reportable Incidents Reporting Incidents The table below shows what events must and must not be reported to achieve compliance with 55 Pa.Code 2600.16(c).

More information

FIRST at Blue Ridge, Inc.

FIRST at Blue Ridge, Inc. FIRST at Blue Ridge, Inc. Application for Admission FIRST at Blue Ridge, Inc. 32 Knox Road Ridgecrest, NC 28770 www.firstinc.org Important For this application to be considered, All forms must be filled

More information

Interim Commissioner Lauren A. Smith and Members of the Public Health Council

Interim Commissioner Lauren A. Smith and Members of the Public Health Council DEVAL L. PATRICK GOVERNOR TIMOTHY P. MURRAY LIEUTENANT GOVERNOR JOHN W. POLANOWICZ SECRETARY LAUREN A. SMITH, MD, MPH INTERIM COMMISSIONER The Commonwealth of Massachusetts Executive Office of Health and

More information